Gynecologic Cancer News

Primary endpoints of randomized clinical trials for cancer therapies frequently change after trial initiation, according to findings published in JAMA Network Open.

Cancer survivors delayed or forwent care more often than those in the general population because their clinician was of another identity, according to a research letter published in JAMA Oncology.

When I graduated from oncology fellowship in 2015, I went straight into an academic position thinking that I would continue to pursue my goals of early drug development and phase 1 clinical trials.

Obesity-related cancer mortality rates tended to be higher in counties with limited access to grocery stores or greater access to fast food, according to data published in JAMA Oncology.

Mirvetuximab soravtansine-gynx conferred a 33% reduction in risk for death compared with chemotherapy for women with folate receptor alpha-positive platinum-resistant ovarian cancer, according to topline data from the agent’s manufacturer.

Asthma appeared associated with a 1.36-fold increased risk for developing cancer, according to research conducted at University of Florida.

Cancers with high vs. low tumor mutational burden appeared significantly associated with improved clinical outcomes among patients treated with immune checkpoint inhibitors, according to data published in JAMA Network Open.

A mailed DVD with information about personal cancer risks, particularly when followed by a phone call from a patient navigator, increased adherence to recommended screenings among rural women at modest costs, according to study data.

Knowledge, expectations and attitudes of patients with cancer about genomic tumor testing appeared to be associated with their respective education and income levels, according to a study published in JCO Precision Oncology.

A high percentage of people with cancer exhibit what are known as SPPADE symptoms, according to study results.